Module

Barriers to Clinical Trial Accrual and Recommendations for Improvement

Source: Research Priorities in Non-Small-Cell Lung Cancer

Barriers to Clinical Trial Accrual and Recommendations for Improvement

Faculty:

Walter J. Curran, MD

CME CREDIT INFORMATION

Release Date: 02/27/07

Expiration Date: 02/26/08

Physicians: maximum of 0.5 AMA PRA Category 1 Credits™

Registered Nurses: 0.6 Nursing CE credits

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Identify the primary barriers to patient accrual in non-small-cell lung cancer clinical trials
Recall current statistics regarding lung cancer in the United States
Describe the current state of lung cancer clinical trial accrual and prioritization of increasing these numbers

Topics covered include:

Introduction
Role of the Coalition
Scope of Problem
Lung Cancer Trials: Accrual Overview
Priority Issues in Lung Cancer Trial Accrual

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.